Global Narcotic (Opioid) Drugs Market Research Report 2024(Status and Outlook)
Report Overview
Narcotics, also called opioids, are a necessary and important part of medical care. They include strong prescription pain relievers, such as oxycodone, hydrocodone, fentanyl, and tramadol. The illegal drug heroin is also an opioid. Some opioids are made from the opium plant, and others are synthetic (man-made).
This report provides a deep insight into the global Narcotic (Opioid) Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Narcotic (Opioid) Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Narcotic (Opioid) Drugs market in any manner.
Global Narcotic (Opioid) Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Merck
Mylan
Hikma Pharmaceuticals
Sun Pharma
Endo Pharmaceuticals
Allergan
Market Segmentation (by Type)
Codeine
Fentanyl
Hydrocodone
Hydromorphone
Meperidine
Methadone
Others
Market Segmentation (by Application)
Pain Relief Application
Anesthesia Application
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Narcotic (Opioid) Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Narcotics, also called opioids, are a necessary and important part of medical care. They include strong prescription pain relievers, such as oxycodone, hydrocodone, fentanyl, and tramadol. The illegal drug heroin is also an opioid. Some opioids are made from the opium plant, and others are synthetic (man-made).
This report provides a deep insight into the global Narcotic (Opioid) Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Narcotic (Opioid) Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Narcotic (Opioid) Drugs market in any manner.
Global Narcotic (Opioid) Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Merck
Mylan
Hikma Pharmaceuticals
Sun Pharma
Endo Pharmaceuticals
Allergan
Market Segmentation (by Type)
Codeine
Fentanyl
Hydrocodone
Hydromorphone
Meperidine
Methadone
Others
Market Segmentation (by Application)
Pain Relief Application
Anesthesia Application
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Narcotic (Opioid) Drugs Market
- Overview of the regional outlook of the Narcotic (Opioid) Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Narcotic (Opioid) Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Narcotic (Opioid) Drugs
1.2 Key Market Segments
1.2.1 Narcotic (Opioid) Drugs Segment by Type
1.2.2 Narcotic (Opioid) Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NARCOTIC (OPIOID) DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Narcotic (Opioid) Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Narcotic (Opioid) Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NARCOTIC (OPIOID) DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Narcotic (Opioid) Drugs Sales by Manufacturers (2019-2024)
3.2 Global Narcotic (Opioid) Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Narcotic (Opioid) Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Narcotic (Opioid) Drugs Sales Sites, Area Served, Product Type
3.6 Narcotic (Opioid) Drugs Market Competitive Situation and Trends
3.6.1 Narcotic (Opioid) Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Narcotic (Opioid) Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NARCOTIC (OPIOID) DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Narcotic (Opioid) Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NARCOTIC (OPIOID) DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NARCOTIC (OPIOID) DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Narcotic (Opioid) Drugs Sales Market Share by Type (2019-2024)
6.3 Global Narcotic (Opioid) Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Narcotic (Opioid) Drugs Price by Type (2019-2024)
7 NARCOTIC (OPIOID) DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Narcotic (Opioid) Drugs Market Sales by Application (2019-2024)
7.3 Global Narcotic (Opioid) Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Narcotic (Opioid) Drugs Sales Growth Rate by Application (2019-2024)
8 NARCOTIC (OPIOID) DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Narcotic (Opioid) Drugs Sales by Region
8.1.1 Global Narcotic (Opioid) Drugs Sales by Region
8.1.2 Global Narcotic (Opioid) Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Narcotic (Opioid) Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Narcotic (Opioid) Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Narcotic (Opioid) Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Narcotic (Opioid) Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Narcotic (Opioid) Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Narcotic (Opioid) Drugs Basic Information
9.1.2 Pfizer Narcotic (Opioid) Drugs Product Overview
9.1.3 Pfizer Narcotic (Opioid) Drugs Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Narcotic (Opioid) Drugs SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Teva
9.2.1 Teva Narcotic (Opioid) Drugs Basic Information
9.2.2 Teva Narcotic (Opioid) Drugs Product Overview
9.2.3 Teva Narcotic (Opioid) Drugs Product Market Performance
9.2.4 Teva Business Overview
9.2.5 Teva Narcotic (Opioid) Drugs SWOT Analysis
9.2.6 Teva Recent Developments
9.3 Purdue Pharma
9.3.1 Purdue Pharma Narcotic (Opioid) Drugs Basic Information
9.3.2 Purdue Pharma Narcotic (Opioid) Drugs Product Overview
9.3.3 Purdue Pharma Narcotic (Opioid) Drugs Product Market Performance
9.3.4 Purdue Pharma Narcotic (Opioid) Drugs SWOT Analysis
9.3.5 Purdue Pharma Business Overview
9.3.6 Purdue Pharma Recent Developments
9.4 Mallinckrodt
9.4.1 Mallinckrodt Narcotic (Opioid) Drugs Basic Information
9.4.2 Mallinckrodt Narcotic (Opioid) Drugs Product Overview
9.4.3 Mallinckrodt Narcotic (Opioid) Drugs Product Market Performance
9.4.4 Mallinckrodt Business Overview
9.4.5 Mallinckrodt Recent Developments
9.5 Amneal Pharma
9.5.1 Amneal Pharma Narcotic (Opioid) Drugs Basic Information
9.5.2 Amneal Pharma Narcotic (Opioid) Drugs Product Overview
9.5.3 Amneal Pharma Narcotic (Opioid) Drugs Product Market Performance
9.5.4 Amneal Pharma Business Overview
9.5.5 Amneal Pharma Recent Developments
9.6 Collegium
9.6.1 Collegium Narcotic (Opioid) Drugs Basic Information
9.6.2 Collegium Narcotic (Opioid) Drugs Product Overview
9.6.3 Collegium Narcotic (Opioid) Drugs Product Market Performance
9.6.4 Collegium Business Overview
9.6.5 Collegium Recent Developments
9.7 Johnson and Johnson
9.7.1 Johnson and Johnson Narcotic (Opioid) Drugs Basic Information
9.7.2 Johnson and Johnson Narcotic (Opioid) Drugs Product Overview
9.7.3 Johnson and Johnson Narcotic (Opioid) Drugs Product Market Performance
9.7.4 Johnson and Johnson Business Overview
9.7.5 Johnson and Johnson Recent Developments
9.8 Merck
9.8.1 Merck Narcotic (Opioid) Drugs Basic Information
9.8.2 Merck Narcotic (Opioid) Drugs Product Overview
9.8.3 Merck Narcotic (Opioid) Drugs Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
9.9 Mylan
9.9.1 Mylan Narcotic (Opioid) Drugs Basic Information
9.9.2 Mylan Narcotic (Opioid) Drugs Product Overview
9.9.3 Mylan Narcotic (Opioid) Drugs Product Market Performance
9.9.4 Mylan Business Overview
9.9.5 Mylan Recent Developments
9.10 Hikma Pharmaceuticals
9.10.1 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Basic Information
9.10.2 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product Overview
9.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product Market Performance
9.10.4 Hikma Pharmaceuticals Business Overview
9.10.5 Hikma Pharmaceuticals Recent Developments
9.11 Sun Pharma
9.11.1 Sun Pharma Narcotic (Opioid) Drugs Basic Information
9.11.2 Sun Pharma Narcotic (Opioid) Drugs Product Overview
9.11.3 Sun Pharma Narcotic (Opioid) Drugs Product Market Performance
9.11.4 Sun Pharma Business Overview
9.11.5 Sun Pharma Recent Developments
9.12 Endo Pharmaceuticals
9.12.1 Endo Pharmaceuticals Narcotic (Opioid) Drugs Basic Information
9.12.2 Endo Pharmaceuticals Narcotic (Opioid) Drugs Product Overview
9.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Product Market Performance
9.12.4 Endo Pharmaceuticals Business Overview
9.12.5 Endo Pharmaceuticals Recent Developments
9.13 Allergan
9.13.1 Allergan Narcotic (Opioid) Drugs Basic Information
9.13.2 Allergan Narcotic (Opioid) Drugs Product Overview
9.13.3 Allergan Narcotic (Opioid) Drugs Product Market Performance
9.13.4 Allergan Business Overview
9.13.5 Allergan Recent Developments
10 NARCOTIC (OPIOID) DRUGS MARKET FORECAST BY REGION
10.1 Global Narcotic (Opioid) Drugs Market Size Forecast
10.2 Global Narcotic (Opioid) Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Narcotic (Opioid) Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Narcotic (Opioid) Drugs Market Size Forecast by Region
10.2.4 South America Narcotic (Opioid) Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Narcotic (Opioid) Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Narcotic (Opioid) Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Narcotic (Opioid) Drugs by Type (2025-2030)
11.1.2 Global Narcotic (Opioid) Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Narcotic (Opioid) Drugs by Type (2025-2030)
11.2 Global Narcotic (Opioid) Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Narcotic (Opioid) Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Narcotic (Opioid) Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Narcotic (Opioid) Drugs
1.2 Key Market Segments
1.2.1 Narcotic (Opioid) Drugs Segment by Type
1.2.2 Narcotic (Opioid) Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NARCOTIC (OPIOID) DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Narcotic (Opioid) Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Narcotic (Opioid) Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NARCOTIC (OPIOID) DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Narcotic (Opioid) Drugs Sales by Manufacturers (2019-2024)
3.2 Global Narcotic (Opioid) Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Narcotic (Opioid) Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Narcotic (Opioid) Drugs Sales Sites, Area Served, Product Type
3.6 Narcotic (Opioid) Drugs Market Competitive Situation and Trends
3.6.1 Narcotic (Opioid) Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Narcotic (Opioid) Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NARCOTIC (OPIOID) DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Narcotic (Opioid) Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NARCOTIC (OPIOID) DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NARCOTIC (OPIOID) DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Narcotic (Opioid) Drugs Sales Market Share by Type (2019-2024)
6.3 Global Narcotic (Opioid) Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Narcotic (Opioid) Drugs Price by Type (2019-2024)
7 NARCOTIC (OPIOID) DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Narcotic (Opioid) Drugs Market Sales by Application (2019-2024)
7.3 Global Narcotic (Opioid) Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Narcotic (Opioid) Drugs Sales Growth Rate by Application (2019-2024)
8 NARCOTIC (OPIOID) DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Narcotic (Opioid) Drugs Sales by Region
8.1.1 Global Narcotic (Opioid) Drugs Sales by Region
8.1.2 Global Narcotic (Opioid) Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Narcotic (Opioid) Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Narcotic (Opioid) Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Narcotic (Opioid) Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Narcotic (Opioid) Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Narcotic (Opioid) Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Narcotic (Opioid) Drugs Basic Information
9.1.2 Pfizer Narcotic (Opioid) Drugs Product Overview
9.1.3 Pfizer Narcotic (Opioid) Drugs Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Narcotic (Opioid) Drugs SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Teva
9.2.1 Teva Narcotic (Opioid) Drugs Basic Information
9.2.2 Teva Narcotic (Opioid) Drugs Product Overview
9.2.3 Teva Narcotic (Opioid) Drugs Product Market Performance
9.2.4 Teva Business Overview
9.2.5 Teva Narcotic (Opioid) Drugs SWOT Analysis
9.2.6 Teva Recent Developments
9.3 Purdue Pharma
9.3.1 Purdue Pharma Narcotic (Opioid) Drugs Basic Information
9.3.2 Purdue Pharma Narcotic (Opioid) Drugs Product Overview
9.3.3 Purdue Pharma Narcotic (Opioid) Drugs Product Market Performance
9.3.4 Purdue Pharma Narcotic (Opioid) Drugs SWOT Analysis
9.3.5 Purdue Pharma Business Overview
9.3.6 Purdue Pharma Recent Developments
9.4 Mallinckrodt
9.4.1 Mallinckrodt Narcotic (Opioid) Drugs Basic Information
9.4.2 Mallinckrodt Narcotic (Opioid) Drugs Product Overview
9.4.3 Mallinckrodt Narcotic (Opioid) Drugs Product Market Performance
9.4.4 Mallinckrodt Business Overview
9.4.5 Mallinckrodt Recent Developments
9.5 Amneal Pharma
9.5.1 Amneal Pharma Narcotic (Opioid) Drugs Basic Information
9.5.2 Amneal Pharma Narcotic (Opioid) Drugs Product Overview
9.5.3 Amneal Pharma Narcotic (Opioid) Drugs Product Market Performance
9.5.4 Amneal Pharma Business Overview
9.5.5 Amneal Pharma Recent Developments
9.6 Collegium
9.6.1 Collegium Narcotic (Opioid) Drugs Basic Information
9.6.2 Collegium Narcotic (Opioid) Drugs Product Overview
9.6.3 Collegium Narcotic (Opioid) Drugs Product Market Performance
9.6.4 Collegium Business Overview
9.6.5 Collegium Recent Developments
9.7 Johnson and Johnson
9.7.1 Johnson and Johnson Narcotic (Opioid) Drugs Basic Information
9.7.2 Johnson and Johnson Narcotic (Opioid) Drugs Product Overview
9.7.3 Johnson and Johnson Narcotic (Opioid) Drugs Product Market Performance
9.7.4 Johnson and Johnson Business Overview
9.7.5 Johnson and Johnson Recent Developments
9.8 Merck
9.8.1 Merck Narcotic (Opioid) Drugs Basic Information
9.8.2 Merck Narcotic (Opioid) Drugs Product Overview
9.8.3 Merck Narcotic (Opioid) Drugs Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
9.9 Mylan
9.9.1 Mylan Narcotic (Opioid) Drugs Basic Information
9.9.2 Mylan Narcotic (Opioid) Drugs Product Overview
9.9.3 Mylan Narcotic (Opioid) Drugs Product Market Performance
9.9.4 Mylan Business Overview
9.9.5 Mylan Recent Developments
9.10 Hikma Pharmaceuticals
9.10.1 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Basic Information
9.10.2 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product Overview
9.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product Market Performance
9.10.4 Hikma Pharmaceuticals Business Overview
9.10.5 Hikma Pharmaceuticals Recent Developments
9.11 Sun Pharma
9.11.1 Sun Pharma Narcotic (Opioid) Drugs Basic Information
9.11.2 Sun Pharma Narcotic (Opioid) Drugs Product Overview
9.11.3 Sun Pharma Narcotic (Opioid) Drugs Product Market Performance
9.11.4 Sun Pharma Business Overview
9.11.5 Sun Pharma Recent Developments
9.12 Endo Pharmaceuticals
9.12.1 Endo Pharmaceuticals Narcotic (Opioid) Drugs Basic Information
9.12.2 Endo Pharmaceuticals Narcotic (Opioid) Drugs Product Overview
9.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Product Market Performance
9.12.4 Endo Pharmaceuticals Business Overview
9.12.5 Endo Pharmaceuticals Recent Developments
9.13 Allergan
9.13.1 Allergan Narcotic (Opioid) Drugs Basic Information
9.13.2 Allergan Narcotic (Opioid) Drugs Product Overview
9.13.3 Allergan Narcotic (Opioid) Drugs Product Market Performance
9.13.4 Allergan Business Overview
9.13.5 Allergan Recent Developments
10 NARCOTIC (OPIOID) DRUGS MARKET FORECAST BY REGION
10.1 Global Narcotic (Opioid) Drugs Market Size Forecast
10.2 Global Narcotic (Opioid) Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Narcotic (Opioid) Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Narcotic (Opioid) Drugs Market Size Forecast by Region
10.2.4 South America Narcotic (Opioid) Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Narcotic (Opioid) Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Narcotic (Opioid) Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Narcotic (Opioid) Drugs by Type (2025-2030)
11.1.2 Global Narcotic (Opioid) Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Narcotic (Opioid) Drugs by Type (2025-2030)
11.2 Global Narcotic (Opioid) Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Narcotic (Opioid) Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Narcotic (Opioid) Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Narcotic (Opioid) Drugs Market Size Comparison by Region (M USD)
Table 5. Global Narcotic (Opioid) Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Narcotic (Opioid) Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Narcotic (Opioid) Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Narcotic (Opioid) Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2022)
Table 10. Global Market Narcotic (Opioid) Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Narcotic (Opioid) Drugs Sales Sites and Area Served
Table 12. Manufacturers Narcotic (Opioid) Drugs Product Type
Table 13. Global Narcotic (Opioid) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Narcotic (Opioid) Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Narcotic (Opioid) Drugs Market Challenges
Table 22. Global Narcotic (Opioid) Drugs Sales by Type (Kilotons)
Table 23. Global Narcotic (Opioid) Drugs Market Size by Type (M USD)
Table 24. Global Narcotic (Opioid) Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Narcotic (Opioid) Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Narcotic (Opioid) Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Narcotic (Opioid) Drugs Market Size Share by Type (2019-2024)
Table 28. Global Narcotic (Opioid) Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Narcotic (Opioid) Drugs Sales (Kilotons) by Application
Table 30. Global Narcotic (Opioid) Drugs Market Size by Application
Table 31. Global Narcotic (Opioid) Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Narcotic (Opioid) Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Narcotic (Opioid) Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Narcotic (Opioid) Drugs Market Share by Application (2019-2024)
Table 35. Global Narcotic (Opioid) Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Narcotic (Opioid) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Narcotic (Opioid) Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Narcotic (Opioid) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Narcotic (Opioid) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Narcotic (Opioid) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Narcotic (Opioid) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Narcotic (Opioid) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Narcotic (Opioid) Drugs Basic Information
Table 44. Pfizer Narcotic (Opioid) Drugs Product Overview
Table 45. Pfizer Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Narcotic (Opioid) Drugs SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Teva Narcotic (Opioid) Drugs Basic Information
Table 50. Teva Narcotic (Opioid) Drugs Product Overview
Table 51. Teva Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Teva Business Overview
Table 53. Teva Narcotic (Opioid) Drugs SWOT Analysis
Table 54. Teva Recent Developments
Table 55. Purdue Pharma Narcotic (Opioid) Drugs Basic Information
Table 56. Purdue Pharma Narcotic (Opioid) Drugs Product Overview
Table 57. Purdue Pharma Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Purdue Pharma Narcotic (Opioid) Drugs SWOT Analysis
Table 59. Purdue Pharma Business Overview
Table 60. Purdue Pharma Recent Developments
Table 61. Mallinckrodt Narcotic (Opioid) Drugs Basic Information
Table 62. Mallinckrodt Narcotic (Opioid) Drugs Product Overview
Table 63. Mallinckrodt Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Mallinckrodt Business Overview
Table 65. Mallinckrodt Recent Developments
Table 66. Amneal Pharma Narcotic (Opioid) Drugs Basic Information
Table 67. Amneal Pharma Narcotic (Opioid) Drugs Product Overview
Table 68. Amneal Pharma Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Amneal Pharma Business Overview
Table 70. Amneal Pharma Recent Developments
Table 71. Collegium Narcotic (Opioid) Drugs Basic Information
Table 72. Collegium Narcotic (Opioid) Drugs Product Overview
Table 73. Collegium Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Collegium Business Overview
Table 75. Collegium Recent Developments
Table 76. Johnson and Johnson Narcotic (Opioid) Drugs Basic Information
Table 77. Johnson and Johnson Narcotic (Opioid) Drugs Product Overview
Table 78. Johnson and Johnson Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Johnson and Johnson Business Overview
Table 80. Johnson and Johnson Recent Developments
Table 81. Merck Narcotic (Opioid) Drugs Basic Information
Table 82. Merck Narcotic (Opioid) Drugs Product Overview
Table 83. Merck Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Merck Business Overview
Table 85. Merck Recent Developments
Table 86. Mylan Narcotic (Opioid) Drugs Basic Information
Table 87. Mylan Narcotic (Opioid) Drugs Product Overview
Table 88. Mylan Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Mylan Business Overview
Table 90. Mylan Recent Developments
Table 91. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Basic Information
Table 92. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product Overview
Table 93. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Hikma Pharmaceuticals Business Overview
Table 95. Hikma Pharmaceuticals Recent Developments
Table 96. Sun Pharma Narcotic (Opioid) Drugs Basic Information
Table 97. Sun Pharma Narcotic (Opioid) Drugs Product Overview
Table 98. Sun Pharma Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Sun Pharma Business Overview
Table 100. Sun Pharma Recent Developments
Table 101. Endo Pharmaceuticals Narcotic (Opioid) Drugs Basic Information
Table 102. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product Overview
Table 103. Endo Pharmaceuticals Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Endo Pharmaceuticals Business Overview
Table 105. Endo Pharmaceuticals Recent Developments
Table 106. Allergan Narcotic (Opioid) Drugs Basic Information
Table 107. Allergan Narcotic (Opioid) Drugs Product Overview
Table 108. Allergan Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Allergan Business Overview
Table 110. Allergan Recent Developments
Table 111. Global Narcotic (Opioid) Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Narcotic (Opioid) Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Narcotic (Opioid) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Narcotic (Opioid) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Narcotic (Opioid) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Narcotic (Opioid) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Narcotic (Opioid) Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Narcotic (Opioid) Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Narcotic (Opioid) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Narcotic (Opioid) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Narcotic (Opioid) Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Narcotic (Opioid) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Narcotic (Opioid) Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Narcotic (Opioid) Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Narcotic (Opioid) Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Narcotic (Opioid) Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Narcotic (Opioid) Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Narcotic (Opioid) Drugs Market Size Comparison by Region (M USD)
Table 5. Global Narcotic (Opioid) Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Narcotic (Opioid) Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Narcotic (Opioid) Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Narcotic (Opioid) Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2022)
Table 10. Global Market Narcotic (Opioid) Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Narcotic (Opioid) Drugs Sales Sites and Area Served
Table 12. Manufacturers Narcotic (Opioid) Drugs Product Type
Table 13. Global Narcotic (Opioid) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Narcotic (Opioid) Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Narcotic (Opioid) Drugs Market Challenges
Table 22. Global Narcotic (Opioid) Drugs Sales by Type (Kilotons)
Table 23. Global Narcotic (Opioid) Drugs Market Size by Type (M USD)
Table 24. Global Narcotic (Opioid) Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Narcotic (Opioid) Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Narcotic (Opioid) Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Narcotic (Opioid) Drugs Market Size Share by Type (2019-2024)
Table 28. Global Narcotic (Opioid) Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Narcotic (Opioid) Drugs Sales (Kilotons) by Application
Table 30. Global Narcotic (Opioid) Drugs Market Size by Application
Table 31. Global Narcotic (Opioid) Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Narcotic (Opioid) Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Narcotic (Opioid) Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Narcotic (Opioid) Drugs Market Share by Application (2019-2024)
Table 35. Global Narcotic (Opioid) Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Narcotic (Opioid) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Narcotic (Opioid) Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Narcotic (Opioid) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Narcotic (Opioid) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Narcotic (Opioid) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Narcotic (Opioid) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Narcotic (Opioid) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Narcotic (Opioid) Drugs Basic Information
Table 44. Pfizer Narcotic (Opioid) Drugs Product Overview
Table 45. Pfizer Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Narcotic (Opioid) Drugs SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Teva Narcotic (Opioid) Drugs Basic Information
Table 50. Teva Narcotic (Opioid) Drugs Product Overview
Table 51. Teva Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Teva Business Overview
Table 53. Teva Narcotic (Opioid) Drugs SWOT Analysis
Table 54. Teva Recent Developments
Table 55. Purdue Pharma Narcotic (Opioid) Drugs Basic Information
Table 56. Purdue Pharma Narcotic (Opioid) Drugs Product Overview
Table 57. Purdue Pharma Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Purdue Pharma Narcotic (Opioid) Drugs SWOT Analysis
Table 59. Purdue Pharma Business Overview
Table 60. Purdue Pharma Recent Developments
Table 61. Mallinckrodt Narcotic (Opioid) Drugs Basic Information
Table 62. Mallinckrodt Narcotic (Opioid) Drugs Product Overview
Table 63. Mallinckrodt Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Mallinckrodt Business Overview
Table 65. Mallinckrodt Recent Developments
Table 66. Amneal Pharma Narcotic (Opioid) Drugs Basic Information
Table 67. Amneal Pharma Narcotic (Opioid) Drugs Product Overview
Table 68. Amneal Pharma Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Amneal Pharma Business Overview
Table 70. Amneal Pharma Recent Developments
Table 71. Collegium Narcotic (Opioid) Drugs Basic Information
Table 72. Collegium Narcotic (Opioid) Drugs Product Overview
Table 73. Collegium Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Collegium Business Overview
Table 75. Collegium Recent Developments
Table 76. Johnson and Johnson Narcotic (Opioid) Drugs Basic Information
Table 77. Johnson and Johnson Narcotic (Opioid) Drugs Product Overview
Table 78. Johnson and Johnson Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Johnson and Johnson Business Overview
Table 80. Johnson and Johnson Recent Developments
Table 81. Merck Narcotic (Opioid) Drugs Basic Information
Table 82. Merck Narcotic (Opioid) Drugs Product Overview
Table 83. Merck Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Merck Business Overview
Table 85. Merck Recent Developments
Table 86. Mylan Narcotic (Opioid) Drugs Basic Information
Table 87. Mylan Narcotic (Opioid) Drugs Product Overview
Table 88. Mylan Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Mylan Business Overview
Table 90. Mylan Recent Developments
Table 91. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Basic Information
Table 92. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product Overview
Table 93. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Hikma Pharmaceuticals Business Overview
Table 95. Hikma Pharmaceuticals Recent Developments
Table 96. Sun Pharma Narcotic (Opioid) Drugs Basic Information
Table 97. Sun Pharma Narcotic (Opioid) Drugs Product Overview
Table 98. Sun Pharma Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Sun Pharma Business Overview
Table 100. Sun Pharma Recent Developments
Table 101. Endo Pharmaceuticals Narcotic (Opioid) Drugs Basic Information
Table 102. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product Overview
Table 103. Endo Pharmaceuticals Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Endo Pharmaceuticals Business Overview
Table 105. Endo Pharmaceuticals Recent Developments
Table 106. Allergan Narcotic (Opioid) Drugs Basic Information
Table 107. Allergan Narcotic (Opioid) Drugs Product Overview
Table 108. Allergan Narcotic (Opioid) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Allergan Business Overview
Table 110. Allergan Recent Developments
Table 111. Global Narcotic (Opioid) Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Narcotic (Opioid) Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Narcotic (Opioid) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Narcotic (Opioid) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Narcotic (Opioid) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Narcotic (Opioid) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Narcotic (Opioid) Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Narcotic (Opioid) Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Narcotic (Opioid) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Narcotic (Opioid) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Narcotic (Opioid) Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Narcotic (Opioid) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Narcotic (Opioid) Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Narcotic (Opioid) Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Narcotic (Opioid) Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Narcotic (Opioid) Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Narcotic (Opioid) Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Narcotic (Opioid) Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Narcotic (Opioid) Drugs Market Size (M USD), 2019-2030
Figure 5. Global Narcotic (Opioid) Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Narcotic (Opioid) Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Narcotic (Opioid) Drugs Market Size by Country (M USD)
Figure 11. Narcotic (Opioid) Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Narcotic (Opioid) Drugs Revenue Share by Manufacturers in 2023
Figure 13. Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Narcotic (Opioid) Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Narcotic (Opioid) Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Narcotic (Opioid) Drugs Market Share by Type
Figure 18. Sales Market Share of Narcotic (Opioid) Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Narcotic (Opioid) Drugs by Type in 2023
Figure 20. Market Size Share of Narcotic (Opioid) Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Narcotic (Opioid) Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Narcotic (Opioid) Drugs Market Share by Application
Figure 24. Global Narcotic (Opioid) Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Narcotic (Opioid) Drugs Sales Market Share by Application in 2023
Figure 26. Global Narcotic (Opioid) Drugs Market Share by Application (2019-2024)
Figure 27. Global Narcotic (Opioid) Drugs Market Share by Application in 2023
Figure 28. Global Narcotic (Opioid) Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Narcotic (Opioid) Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Narcotic (Opioid) Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Narcotic (Opioid) Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Narcotic (Opioid) Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Narcotic (Opioid) Drugs Sales Market Share by Country in 2023
Figure 37. Germany Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Narcotic (Opioid) Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Narcotic (Opioid) Drugs Sales Market Share by Region in 2023
Figure 44. China Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Narcotic (Opioid) Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Narcotic (Opioid) Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Narcotic (Opioid) Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Narcotic (Opioid) Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Narcotic (Opioid) Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Narcotic (Opioid) Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Narcotic (Opioid) Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Narcotic (Opioid) Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Narcotic (Opioid) Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Narcotic (Opioid) Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Narcotic (Opioid) Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Narcotic (Opioid) Drugs Market Size (M USD), 2019-2030
Figure 5. Global Narcotic (Opioid) Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Narcotic (Opioid) Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Narcotic (Opioid) Drugs Market Size by Country (M USD)
Figure 11. Narcotic (Opioid) Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Narcotic (Opioid) Drugs Revenue Share by Manufacturers in 2023
Figure 13. Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Narcotic (Opioid) Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Narcotic (Opioid) Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Narcotic (Opioid) Drugs Market Share by Type
Figure 18. Sales Market Share of Narcotic (Opioid) Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Narcotic (Opioid) Drugs by Type in 2023
Figure 20. Market Size Share of Narcotic (Opioid) Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Narcotic (Opioid) Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Narcotic (Opioid) Drugs Market Share by Application
Figure 24. Global Narcotic (Opioid) Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Narcotic (Opioid) Drugs Sales Market Share by Application in 2023
Figure 26. Global Narcotic (Opioid) Drugs Market Share by Application (2019-2024)
Figure 27. Global Narcotic (Opioid) Drugs Market Share by Application in 2023
Figure 28. Global Narcotic (Opioid) Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Narcotic (Opioid) Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Narcotic (Opioid) Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Narcotic (Opioid) Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Narcotic (Opioid) Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Narcotic (Opioid) Drugs Sales Market Share by Country in 2023
Figure 37. Germany Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Narcotic (Opioid) Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Narcotic (Opioid) Drugs Sales Market Share by Region in 2023
Figure 44. China Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Narcotic (Opioid) Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Narcotic (Opioid) Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Narcotic (Opioid) Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Narcotic (Opioid) Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Narcotic (Opioid) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Narcotic (Opioid) Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Narcotic (Opioid) Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Narcotic (Opioid) Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Narcotic (Opioid) Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Narcotic (Opioid) Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Narcotic (Opioid) Drugs Market Share Forecast by Application (2025-2030)
